Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tissue Renewal without Stem Cells

Tissue Renewal without Stem Cells

After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...

Stem Cell Culture

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Liver Transplantation Following Organ Donation After Medical Assistance in Dying: One Step Further.

Transplantation·2026

Same author

Metformin suppresses β-cell apoptosis under ER stress by inhibiting protein translation.

Metabolism: clinical and experimental·2026

Same author

Correction: Extracellular Matrix-Guided Islet Cell Transplantation Results in Improved Glycemic Control in a NOD-SCID Mouse Model.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2026

Same author

Autologous and allogeneic stem cell-derived islet therapy in three recipients with type 1 diabetes and complete loss of endogenous pancreatic β-cell function pretransplant.

The lancet. Diabetes & endocrinology·2026

Same author

2025 Canadian Surgery Forum: Sept. 17-20, 2025.

Canadian journal of surgery. Journal canadien de chirurgie·2025

Same author

Liver Transplantation Outcomes in Younger Versus Older Adult Recipients: The Edmonton Experience.

Journal of transplantation·2025

Search research articles

Related Experiment Video

Updated: Jun 19, 2026

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers

Published on: March 3, 2023

Are stem cells a cure for diabetes?

Michael D McCall¹, Christian Toso, Emmanuel E Baetge

¹Department of Surgery, University of Alberta, Edmonton, Alberta, Canada.

Clinical Science (London, England : 1979)

|October 8, 2009

Summary

Stem cell therapy offers a promising alternative to organ donation for Type 1 diabetes, aiming to generate insulin-producing cells. Research explores both adult and embryonic stem cells, considering their potential and limitations for diabetic patients.

More Related Videos

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Published on: November 18, 2022

A Quick and Efficient Method for the Purification of Endoderm Cells Generated from Human Embryonic Stem Cells

A Quick and Efficient Method for the Purification of Endoderm Cells Generated from Human Embryonic Stem Cells

Published on: March 3, 2016

Related Experiment Videos

Last Updated: Jun 19, 2026

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers

Published on: March 3, 2023

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Published on: November 18, 2022

A Quick and Efficient Method for the Purification of Endoderm Cells Generated from Human Embryonic Stem Cells

A Quick and Efficient Method for the Purification of Endoderm Cells Generated from Human Embryonic Stem Cells

Published on: March 3, 2016

Area of Science:

Biomedical research
Regenerative medicine
Endocrinology

Background:

Type 1 diabetes requires ongoing management due to the pancreas's inability to produce insulin.
Islet transplantation is limited by organ donor availability.
Stem cell-derived cells offer a potential alternative for insulin replacement therapy.

Purpose of the Study:

To review the progress in utilizing adult and embryonic stem cells for diabetes treatment.
To evaluate the potential of stem cell therapy as an alternative to islet transplantation.
To discuss the limitations and potential complications of stem cell therapy for diabetes.

Main Methods:

Review of current research on adult stem cells for insulin production.
Review of current research on embryonic stem cells for insulin production.
Analysis of ethical considerations and potential risks, such as teratoma formation.

Main Results:

Both adult and embryonic stem cells show promise in generating insulin-producing cells.
Embryonic stem cells have demonstrated potential in early mouse models.
Adult stem cells avoid the ethical debate surrounding embryonic stem cells.

Conclusions:

Stem cell therapy is a developing field for treating Type 1 diabetes.
Further research is needed to overcome limitations and ensure safety, including teratoma risk.
The choice between adult and embryonic stem cells involves balancing potential benefits and ethical considerations.